GlassScriptPhysician profile
Alfred Mason Holden
NPI 1205899952
$1,609.94
in general payments reported to CMS, 2019-2025
26 companies · $16.95 in 2025
The $16.95 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $71.25 · 2021: $129 · 2022: $411 · 2023: $211 · 2024: $470 · 2025: $16.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Entertainment: $14.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.94 |
| Entertainment | $14.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $461.34 | 2019-2024 | Xtandi |
| Boston Scientific Corporation | $205.52 | 2019-2024 | Lithovue, Rezum Generator |
| Olympus America INC. | $123.85 | 2022-2024 | Itind System |
| Dendreon Pharmaceuticals LLC | $96.74 | 2019-2022 | |
| Innovation Technologies INC | $69.94 | 2022-2024 | Irrisept |
| Axonics, INC. | $64.56 | 2022-2023 | Axonics |
| Merck Sharp & Dohme LLC | $64.25 | 2020-2023 | Keytruda, Lynparza |
| Laborie Medical Technologies Corp. | $56.68 | 2022 | |
| Verity Pharmaceuticals INC. | $55.68 | 2023-2025 | Trelstar |
| Coloplast Corp | $54.14 | 2023-2024 | Titan |
| Abbvie INC. | $40.42 | 2022 | |
| Urovant Sciences INC | $37.93 | 2021-2022 | |
| Antares Pharma, INC. | $34.40 | 2019-2022 | |
| Medtronic, INC. | $30.99 | 2024 | Interstim |
| Progenics Pharmaceuticals, INC. | $25.77 | 2023 | Pylarify |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $23.93 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.66 | 2023 | |
| Alexion Pharmaceuticals, INC. | $19.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.10 | 2019 | |
| Sun Pharmaceutical Industries INC. | $18.47 | 2022 | |
| Ethicon US, LLC | $17.38 | 2023 | Echelon Flex |
| Takeda Pharmaceuticals U.S.A., INC. | $15.49 | 2021 | |
| Provepharm INC. | $14.11 | 2023 | Bludigo |
| Astrazeneca Pharmaceuticals LP | $13.84 | 2023 | Lynparza |
| Acerus Pharmaceuticals Corporation | $12.33 | 2022 | |
| Procept Biorobotics Corporation | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Holden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.